锦波生物
(920982)
| 流通市值：68.44亿 | | | 总市值：141.99亿 |
| 流通股本：5546.51万 | | | 总股本：1.15亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 771,082,522.84 | 375,372,555.96 | 1,595,372,919.28 | 1,295,732,666.6 |
| 营业总成本 | 445,677,659.51 | 218,368,822.25 | 825,957,509.81 | 620,389,060.82 |
| 其他经营收益 | | | | |
| 营业利润 | 335,975,450.99 | 167,066,838.57 | 768,287,154.22 | 671,048,448.28 |
| 利润总额 | 335,409,972.32 | 166,964,686.52 | 760,360,294.82 | 666,696,461.51 |
| 净利润 | 282,159,334.78 | 140,959,085.69 | 645,710,506.58 | 564,640,017.15 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 282,159,334.78 | 140,959,085.69 | 645,710,506.58 | 564,640,017.15 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,704,692,801.16 | 1,628,729,877.56 | 1,497,188,110.87 | 1,417,258,251.64 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,162,013,382.86 | 1,082,212,801.64 | 1,086,667,206.46 | 1,044,968,603.65 |
| 资产总计 | 2,866,706,184.02 | 2,710,942,679.2 | 2,583,855,317.33 | 2,462,226,855.29 |
| 流动负债: | | | | |
| 流动负债合计 | 453,775,429.99 | 398,627,670.27 | 370,108,552.68 | 419,419,228.08 |
| 非流动负债: | | | | |
| 非流动负债合计 | 375,040,433.02 | 276,626,420.14 | 320,017,261.55 | 202,635,059.8 |
| 负债合计 | 828,815,863.01 | 675,254,090.41 | 690,125,814.23 | 622,054,287.88 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,037,740,052.14 | 2,035,708,822.39 | 1,895,253,856.52 | 1,841,911,788.68 |
| 股东权益合计 | 2,037,890,321.01 | 2,035,688,588.79 | 1,893,729,503.1 | 1,840,172,567.41 |
| 负债和股东权益合计 | 2,866,706,184.02 | 2,710,942,679.2 | 2,583,855,317.33 | 2,462,226,855.29 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 821,552,280.24 | 418,056,174.78 | 1,783,849,594.02 | 1,380,543,735.07 |
| 经营活动现金流出小计 | 528,526,647.87 | 255,006,678.41 | 1,153,847,404.03 | 826,320,515.87 |
| 经营活动产生的现金流量净额 | 293,025,632.37 | 163,049,496.37 | 630,002,189.99 | 554,223,219.2 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,454,873,311.79 | 802,052,393.98 | 2,406,279,537.9 | 1,654,889,164.88 |
| 投资活动现金流出小计 | 1,520,311,437.77 | 835,232,150.81 | 2,801,022,228.53 | 1,959,959,008.52 |
| 投资活动产生的现金流量净额 | -65,438,125.98 | -33,179,756.83 | -394,742,690.63 | -305,069,843.64 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 81,000,000 | 1,000,000 | 155,400,000 | 9,400,000 |
| 筹资活动现金流出小计 | 154,838,443.69 | 5,969,976.99 | 339,505,299.64 | 319,903,733.26 |
| 筹资活动产生的现金流量净额 | -73,838,443.69 | -4,969,976.99 | -184,105,299.64 | -310,503,733.26 |
| 汇率变动对现金及现金等价物的影响 | -474,187.92 | -121,397.27 | -131,991.98 | -56,021.17 |
| 现金及现金等价物净增加额 | 153,274,874.78 | 124,778,365.28 | 51,022,207.74 | -61,406,378.87 |
| 期末现金及现金等价物余额 | 1,145,421,845.92 | 1,116,925,336.42 | 992,146,971.14 | 879,718,384.53 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 153,274,874.78 | - | 51,022,207.74 | - |